220 likes | 630 Views
LNH 93 study Aa-IPI number of patients randomized. Journ
E N D
1. LNH 93 studyAa-IPI
8. GELA - LNH 93Third multicenter study on aggressive lymphoma
9. LNH 93-5
10. LNH 93-5
11. LNH 93-5
14. Event free survival was significantly better for patients treated with ACVBP.
At 3 years EFS was estimated to be 46% in the ACVBP group and 34 in the CHOP group Event free survival was significantly better for patients treated with ACVBP.
At 3 years EFS was estimated to be 46% in the ACVBP group and 34 in the CHOP group
15. However, overall survival did not differ significantly according to treatment group.
At 3 years, 53% of the patients treated with ACVBP were estimated to be alive as compared with 44% inthe CHOP groupHowever, overall survival did not differ significantly according to treatment group.
At 3 years, 53% of the patients treated with ACVBP were estimated to be alive as compared with 44% inthe CHOP group
16. 93-1IPI : 0, < 60y
17. 93-1IPI : 0, < 60y
18. 93-1IPI : 0, < 60y
19. 93-1IPI : 0, < 60y
20. LNH93-1studyevent-free survival